Research Article
Adherence to Antihypertensive Medications in Iranian Patients
Table 3
Comparison of number of antihypertensives and comorbidities between low and moderate/high adherence groups among 280 Iranian hypertensive patients.
| | Total () | Low adherers () | Moderate/high adherers () | Sig. |
| Antihypertensive therapy | | | | | Monotherapy | 127 (45.3%) | 68 (53.5%) | 59 (46.5%) | 0.234 | Combination therapy | 153 (54.6%) | 71 (46.4%) | 82 (53.6%) | Number of antihypertensive(s) classes taken | | | | | 1 | 127 (45.3%) | 68 (53.5%) | 59 (46.5%) | 0.079 | 2 | 95 (34%) | 37 (38.9%) | 58 (61.1%) | 3–5 | 58 (20.7%) | 34 (58.6%) | 24 (41.4%) | Presence of comorbidity | 160 (57.1%) | 77 (48.1%) | 83 (51.9%) | 0.629 | Mean (±SD) number of comorbidities, patients with at least one comorbidity | 1.54 (±0.76) | 1.53 (±0.75) | 1.54 (±0.77) | 0.984 | Taking anti-hypertensive from pharmacy without doctor visit | 212 (75.7%) | 113 (53.3%) | 99 (46.7%) | 0.031 |
|
|